MacroGenics (MGNX)
(Real Time Quote from BATS)
$3.48 USD
-0.35 (-9.14%)
Updated Aug 5, 2024 10:12 AM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 40% (101 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.27 | 1.69 | 9.99 |
Current Quarter Estimate | -0.47 | 5.88 | 61.00 |
Year Ago Quarter Estimate | -0.36 | 4.88 | 54.84 |
Next Quarter Estimate | -0.07 | 7.06 | 63.00 |
Next Year Estimate | -2.17 | 39.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 11.06 | 12.10 | 15.67 |
Next Year | -17.30 | 25.30 | 11.34 |
Last 5 Years | NA | 3.70 | 8.10 |
Next 5 Years | NA | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 2.26 | 2.05 |
Price/Cash Flow (MRFY) | NA | 10.98 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -53.60% | 11.36% |
Return on Equity (TTM) | -98.01% | 13.81% |
Debt to Equity (MRQ) | NA | 32.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.